|
| Host benefit | Microbial trait implicated | Reference1 |
|
| Immune modulation | | |
| Stimulation of immunity | Enhance T-cell numbers and activity levels | [13] |
| Dampening of inflammation | Promote anti-inflammatory cytokine production | [14] |
| Pathogen burden reduction | Competitive exclusion | [15] |
| Direct antagonism | [16, 17] |
| Uncharacterised | [18, 19] |
| Improved gut barrier function | Promote gut barrier integrity | [20] |
| Reduced cancer risk | Detoxification of carcinogenic metabolites | [21] |
| Reduced atopic allergy symptoms | Suppression of hypersensitivity | [22] |
| Reduced cardiovascular disease risk | Cholesterol reduction by deconjugation of bile salts | [23, 24] |
| Production of anti-hypertensive peptides | [25] |
| Alleviation of dietary intolerance | Catabolism of dietary ingredients | [26] |
| Enhanced nutrient value | Vitamin and co-factor production | [27] |
| Alleviation of IBS2 symptoms | Not defined | [28, 29] |
|